Pharmaceutical

STAT+: Senators start work on Medicare physician paymen...

A bipartisan group of senators is starting to work on long-term fixes to issues ...

Does Moderna’s RSV vaccine lose efficacy faster than ot...

Follow-up data from Moderna’s Phase 3 RSV vaccine trial reveals that its efficac...

STAT+: Pharmalittle: We’re reading about a U.S. vaccine...

A medical journal has retracted two studies claiming to show the harms of the ab...

Verekitug by Upstream Bio for Rhinosinusitis: Likelihoo...

Verekitug is under clinical development by Upstream Bio and currently in Phase I...

Tapotoclax by Amgen for Myelodysplastic Syndrome: Likel...

Tapotoclax is under clinical development by Amgen and currently in Phase I for M...

Tapotoclax by Amgen for Chronic Myelomonocytic Leukemia...

Tapotoclax is under clinical development by Amgen and currently in Phase I for C...

Vorolanib by EyePoint Pharmaceuticals for Diabetic Macu...

Vorolanib is under clinical development by EyePoint Pharmaceuticals and currentl...

Monoclonal Antibody Conjugate 3 to Target EGFR for Onco...

Monoclonal Antibody Conjugate 3 to Target EGFR for Oncology is under clinical de...

(Edetate disodium + ethyl alcohol + minocycline hydroch...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...

(Edetate disodium + ethyl alcohol + minocycline hydroch...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...

(Edetate disodium + ethyl alcohol + minocycline hydroch...

(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...

AFM-24I by Affimed for Metastatic Hepatocellular Carcin...

AFM-24I is under clinical development by Affimed and currently in Phase II for M...

INCB-57643 by Incyte for Myelofibrosis: Likelihood of A...

INCB-57643 is under clinical development by Incyte and currently in Phase II for...

STAT+: Years into an addiction crisis, a med school lec...

A university in Florida has been criticized for allowing a lecture that conveyed...

The GLP-1 panic is alive and well

The need-to-know in biotech this morning: —The arrival of Scion Life Sciences —G...

STAT+: Pharmalittle: We’re reading about worries over a...

Eli Lilly is worried a deal to expand production of Novo Nordisk's weight-loss d...